Your browser doesn't support javascript.
loading
E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
Rogers, Jason H; Owens, Kristin S; Kurkewich, Jeffrey; Klopfenstein, Nathan; Iyer, Sangeeta R; Simon, M Celeste; Dahl, Richard.
Afiliación
  • Rogers JH; Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USA.
  • Owens KS; Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USA.
  • Kurkewich J; Biological Science, University of Notre Dame, Notre Dame, IN 46556, USA.
  • Klopfenstein N; Department of Microbiology and Immunology, Indiana University School of Medicine, South Bend, IN 46617, USA.
  • Iyer SR; Abramson Family Cancer Research Institute, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA.
  • Simon MC; Abramson Family Cancer Research Institute, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA.
  • Dahl R; Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USA; Biological Science, University of Notre Dame, Notre Dame, IN 46556, USA; Department of Microbiology and Immunology, Indiana University School of Medicine, South Bend, IN 46617, USA.
Biomed Res Int ; 2016: 3983686, 2016.
Article en En | MEDLINE | ID: mdl-26942192
ABSTRACT
Antagonistic interactions between transcription factors contribute to cell fate decisions made by multipotent hematopoietic progenitor cells. Concentration of the transcription factor PU.1 affects myeloid/lymphoid development with high levels of PU.1 directing myeloid cell fate acquisition at the expense of B cell differentiation. High levels of PU.1 may be required for myelopoiesis in order to overcome inhibition of its activity by transcription factors that promote B cell development. The B cell transcription factors, E2A and EBF, are necessary for commitment of multipotential progenitors and lymphoid primed multipotential progenitors to lymphocytes. In this report we hypothesized that factors required for early B cell commitment would bind to PU.1 and antagonize its ability to induce myeloid differentiation. We investigated whether E2A and/or EBF associate with PU.1. We observed that the E2A component, E47, but not EBF, directly binds to PU.1. Additionally E47 represses PU.1-dependent transactivation of the MCSFR promoter through antagonizing PU.1's ability to bind to DNA. Exogenous E47 expression in hematopoietic cells inhibits myeloid differentiation. Our data suggest that E2A antagonism of PU.1 activity contributes to its ability to commit multipotential hematopoietic progenitors to the lymphoid lineages.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Diferenciación Celular / Transactivadores / Proteínas Proto-Oncogénicas / Proteínas de Unión al ADN / Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomed Res Int Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Diferenciación Celular / Transactivadores / Proteínas Proto-Oncogénicas / Proteínas de Unión al ADN / Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomed Res Int Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos